Somerset Therapeutics
6 federal recalls on file, showing the 4 from the last 12 months. We monitor every CPSC, FDA, USDA, and NHTSA notice for Somerset Therapeutics and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-03-25FDA-DrugClass IIStop using Somerset Therapeutics dexamethasone injection
Somerset Therapeutics is recalling one lot of dexamethasone sodium phosphate injection because testing found impurity levels above acceptable limits as the product approached its expiration date. The affected lot (A240421, expiring 07/31/2026) was distributed nationwide. No injuries have been reported.
- 2025-12-24FDA-DrugClass IIIStop using Somerset Therapeutics cisatracurium besylate
Somerset Therapeutics is recalling cisatracurium besylate injection (a muscle relaxant used during surgery) because stability testing found the drug strength fell below the required standard. Lot A250043 with expiration date 06/30/2026 is affected. The company has not reported any injuries.
- 2025-12-24FDA-DrugClass IIIStop using Somerset cisatracurium besylate injection
Somerset Therapeutics is recalling cisatracurium besylate injection (200mg/20mL vials, Lot #A250020, expiration 06/30/2026) because stability testing found the drug's strength fell below required standards. This means the medication may not work as intended during medical procedures.
- 2025-12-24FDA-DrugClass IIICheck cisatracurium besylate vials for affected lots
Somerset Therapeutics is recalling specific lots of cisatracurium besylate injection because testing found the drug contains less active ingredient than labeled. The affected vials may not work as intended during medical procedures. No injuries have been reported.
Get notified about new Somerset Therapeutics recalls
Free weekly digest. We email when a new federal recall affects Somerset Therapeutics or anything else in your household.
Get the Sunday Brief